Clinical trial

ASPIRIN: Neurodevelopmental Follow-up Trial

NCT04888377

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2021-09-01

PhaseN/A

Study timeline

Study start (actual)2021-09-01Date precision: day

Registry last updated2024-10-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Neurodevelopmental Abnormalityunresolved

Interventions

AspirinDRUG · verified · RxNorm: aspirin

PlaceboDRUG

Sponsors & collaborators

NICHD Global Network for Women's and Children's Healthlead sponsor

Thomas Jefferson Universitycollaborator

RTI Internationalcollaborator

Thrasher Research Fundcollaborator

Mapped research locations

New YorkNew York, United States1 BostonMassachusetts, United States1 PhiladelphiaPennsylvania, United States1 BirminghamAlabama, United States1 DenverColorado, United States1 Chapel HillNorth Carolina, United States1 NewarkDelaware, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04888377 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.